Cyclooxygenase-2-specific inhibitors: Are they safe?

American Journal of Medicine

Volumn 110, Issue 1 SUPPL. 1, 2001, Pages S46-S49

  Schnitzer, Thomas J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

BLEEDING; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SAFETY; EDEMA; ENDOTHELIUM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; ULCER HEALING; WOUND HEALING;

EID: 0035825167     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(00)00650-1     Document Type: Review

References (32)

1. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
2. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial
3. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis
4. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
5. Are surrogate markers adequate to assess cardiovascular disease drugs?
6. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis
7. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
8. Treatment with rofecoxib required less gastrointestinal (GI) comedication and fewer GI procedures than non-specific cyclooxygenase inhibitors (NSAIDs)
9. A comparative study of platelet function in subjects receiving either celecoxib, a specific COX-2 inhibitor, or ibuprofen, a nonspecific inhibitor of cyclooxygenase
10. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 vs COX-1 in healthy volunteers
11. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: Physiologic foundations and clinical implications
12. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: Implication for renal function
13. Immunolocalization of cyclooxygenase-2 in the macula densa of human elderly
14. Regulation of cyclooxygenase expression in the kidney by dietary salt intake
15. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
16. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
17. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial
18. Renal safety profile of rofecoxib, a specific inhibitor of COX-2, in controlled clinical trials
19. Update on aspirin in the treatment and prevention of cardiovascular disease
20. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
21. Cardiovascular safety profile of rofecoxib in controlled clinical trials
22. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats
23. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
24. Cyclooxygenase 2 and wound healing in the stomach
25. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
26. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions
27. Gastrointestinal toxicity with celecoxib versus non-steroidal anti-inflammatory drugs for osteoarthrhtis and rheumatoid arthritis. The CLASS study: A randomized controlled trial
28. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
29. Prostaglandins: Critical roles in pregnancy and colon cancer
30. Multiple female reproductive failures in cyclooxygenase 2-deficient mice
31. Prostaglandins and reproduction - What do knockouts really tell us?
32. The control of labor